Science Explorer Back to mapMap
Discussion
Company · Waltham · United States

NKT Therapeutics (United States)

Research works
90
▲ 652% vs 2018-21
Citations
4.8k
52.6 per fractional work
Top-10% rate
9.5%
all institutions 10.0%
Open access
45%
world 40%
International
27%
world 18%

Not ranked overall: NKT Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does NKT Therapeutics (United States) work in?

In 2022-now, 49% of research at NKT Therapeutics (United States) is in Life Sciences, 48% in Health Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (31%), Immunology and Microbiology (17%). It does 2.7× the world's share of Life Sciences.

Life Sciences: 19 fractional works · 49.3% of its workBiochemistry, Genetics and Molecular Biology: 12 fractional works · 30.7% of its workMolecular Biology: 9 fractional works · 23.6% of its workGenetics: 1 fractional works · 2.0% of its workCancer Research: 1 fractional works · 1.8% of its workCell Biology: 1 fractional works · 1.4% of its workBiotechnology: 0 fractional works · 0.8% of its workEndocrinology: 0 fractional works · 0.5% of its workBiochemistry: 0 fractional works · 0.2% of its workMolecular Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 6 fractional works · 16.9% of its workImmunology: 6 fractional works · 14.6% of its workMicrobiology: 1 fractional works · 2.3% of its workNeuroscience: 1 fractional works · 1.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.3% of its workBiological Psychiatry: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workHealth Sciences: 18 fractional works · 47.9% of its workMedicine: 17 fractional works · 45.4% of its workOncology: 3 fractional works · 7.9% of its workRheumatology: 2 fractional works · 5.4% of its workPhysiology: 2 fractional works · 4.4% of its workEpidemiology: 2 fractional works · 4.1% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 4.0% of its workDermatology: 1 fractional works · 3.9% of its workSurgery: 1 fractional works · 2.4% of its workPathology and Forensic Medicine: 1 fractional works · 2.1% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.8% of its workInfectious Diseases: 0 fractional works · 1.2% of its workImmunology and Allergy: 0 fractional works · 1.0% of its workPsychiatry and Mental health: 0 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.0% of its workPharmacology: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.7% of its workOphthalmology: 0 fractional works · 0.7% of its workReproductive Medicine: 0 fractional works · 0.6% of its workHematology: 0 fractional works · 0.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.5% of its workNephrology: 0 fractional works · 0.3% of its workNursing: 1 fractional works · 1.8% of its workNutrition and Dietetics: 1 fractional works · 1.8% of its workHealth Professions: 0 fractional works · 0.4% of its workPharmacy: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workPhysical Sciences: 1 fractional works · 2.7% of its workComputer Science: 0 fractional works · 0.8% of its workComputational Theory and Mathematics: 0 fractional works · 0.8% of its workChemistry: 0 fractional works · 0.7% of its workOrganic Chemistry: 0 fractional works · 0.5% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.5% of its workEcology: 0 fractional works · 0.5% of its workMaterials Science: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workMathematics: 0 fractional works · 0.2% of its workStatistics and Probability: 0 fractional works · 0.2% of its workEngineering: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 0.1% of its workALL ITS WORKNKT Therapeutics(United States)38fractional works, 2022-now
Life Sciences49%Physical Sciences3%Health Sciences48%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1230.7%
    2. Immunology and Microbiology616.9%
    3. Neuroscience11.6%
    4. Agricultural and Biological Sciences00.1%
    1. Medicine1745.4%
    2. Nursing11.8%
    3. Health Professions00.4%
    4. Veterinary00.3%
    1. Computer Science00.8%
    2. Chemistry00.7%
    3. Environmental Science00.5%
    4. Materials Science00.3%
    5. Mathematics00.2%
    6. Engineering00.2%
    1. Psychology00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.02× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.75× its world share, 12 worksBiochemistry, Geneti…Immunology and Microbiology: 16.83× its world share, 6 worksImmunology and Micro…Neuroscience: 1.00× its world share, 1 worksNeuroscienceChemistry: 0.47× its world share, 0 worksChemistryComputer Science: 0.10× its world share, 0 worksComputer ScienceEngineering: 0.01× its world share, 0 worksEngineeringEnvironmental Science: 0.09× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.08× its world share, 0 worksMaterials ScienceMathematics: 0.19× its world share, 0 worksMathematicsHealth Professions: 0.16× its world share, 0 worksHealth ProfessionsMedicine: 2.36× its world share, 17 worksMedicineNursing: 3.58× its world share, 1 worksNursingVeterinary: 2.36× its world share, 0 worksVeterinaryPsychology: 0.03× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 16.8×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Immunology and Microbiology16.83×6 works
  2. Biochemistry, Genetics and Molecular Biology5.75×12 works
  3. Nursing3.58×1 works
  4. Medicine2.36×17 works
  5. Veterinary2.36×0 works
  6. Neuroscience1.00×1 works
  7. Chemistry0.47×0 works
  8. Mathematics0.19×0 works
  9. Health Professions0.16×0 works
  10. Computer Science0.10×0 works
  11. Environmental Science0.09×0 works
  12. Materials Science0.08×0 works
  13. Psychology0.03×0 works
  14. Agricultural and Biological Sciences0.02×0 works
  15. Engineering0.01×0 works

Who are the top researchers at NKT Therapeutics (United States)?

Ranked on the quality score, Robert D. Mashal, Sai P. Thankamony and Felix Scheuplein lead among researchers whose main affiliation is NKT Therapeutics (United States).

  1. 1 Robert D. Mashal United States · #691,093 worldwide 1.8k citations · 32 works
  2. 2 Sai P. Thankamony United States · #1,400,402 worldwide 859 citations · 15 works
  3. 3 Felix Scheuplein United States · #1,781,661 worldwide 1.7k citations · 36 works
  4. 4 Lukas Dillinger United States · #4,477,308 worldwide 30 citations · 16 works
All ranked researchers at NKT Therapeutics (United States)

What are the most cited papers from NKT Therapeutics (United States)?

The most cited paper from NKT Therapeutics (United States) is "Initial sequencing and analysis of the human genome" (Eric S. Lander et al., 2001), with 24,745 citations. Next come "Initial sequencing and comparative analysis of the mouse genome" (7,343) and "Genome sequence of the Brown Norway rat yields insights into mammalian evolution" (2,224).

Most cited papers
#PaperReleasedCitations
1 Initial sequencing and analysis of the human genome Eric S. Lander et al. · Nature Open access252 authors Feb 2001 24,745
2 Initial sequencing and comparative analysis of the mouse genome Asif T. Chinwalla et al. · Nature Open access223 authors Dec 2002 7,343
3 Genome sequence of the Brown Norway rat yields insights into mammalian evolution Richard A. Gibbs et al. · Nature Open access248 authors Apr 2004 2,224
4 Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome Danny Liaw, Debbie J. Marsh, Jing Li et al. · Nature Genetics May 1997 2,102
5 Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori Richard A. Alm et al. · Nature 14 Jan 1999 1,918
All 60 most cited papers, with filters and sorting

Which keywords describe research at NKT Therapeutics (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer, Inflammation, Cancer Therapy, Regulatory T Cells, Epidemiology, Immune System, TGF-ß and IL-17.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 35 words, with their numbers
  1. Inflammation5▲ 5.9×21 topics
  2. Cancer4▲ 8.4×15 topics
  3. Epidemiology4▲ 2.6×14 topics
  4. Cancer Therapy3▲ 13×10 topics
  5. Regulatory T Cells3▲ 62×2 topics
  6. Treatment2▲ 4.9×6 topics
  7. Immune System2▲ 23×2 topics
  8. TGF-ß2▲ 34×3 topics
  9. Genetics2▲ 7.2×3 topics
  10. IL-172▲ 145×1 topic
  11. Immunology2▲ 46×2 topics
  12. TH17 Cells2▲ 145×1 topic
  13. Immune Dysregulation2▲ 60×2 topics
  14. Metabolism2▲ 9.1×7 topics
  15. Monoclonal Antibodies2▲ 54×2 topics
  16. Transcriptional Regulation2▲ 29×4 topics
  17. Autoantibodies2▲ 19×3 topics
  18. Glycosylation2▲ 41×2 topics
  19. Allergic Diseases2▲ 71×1 topic
  20. Asthma2▲ 43×1 topic
  21. Management2▲ 5.4×5 topics
  22. Tumor Microenvironment2▲ 9.6×6 topics
  23. Angiogenesis2▲ 12×7 topics
  24. Fc Receptors2▲ 73×1 topic
  25. Therapeutic Antibodies2▲ 58×1 topic
  26. Filaggrin1▲ 73×1 topic
  27. Immune Response1▲ 6.0×5 topics
  28. Skin Microbiome1▲ 73×1 topic
  29. Chemotherapy1▲ 4.6×5 topics
  30. Diagnosis1▲ 3.4×3 topics
  31. Signaling1▲ 54×2 topics
  32. Obesity1▲ 3.6×3 topics
  33. Clinical Trials1▲ 4.2×4 topics
  34. Quality of Life1▲ 1.89×3 topics
  35. Therapy1▲ 14×2 topics

Which research topics does NKT Therapeutics (United States) publish most on?

By volume in 2022-now: Psoriasis: Treatment and Pathogenesis, Asthma and respiratory diseases, Monoclonal and Polyclonal Antibodies Research and Dermatology and Skin Diseases.

  1. 1 Psoriasis: Treatment and Pathogenesis Immunology 2 works
  2. 2 Asthma and respiratory diseases Physiology 2 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  4. 4 Dermatology and Skin Diseases Dermatology 1 works
  5. 5 Fibroblast Growth Factor Research Molecular Biology 1 works
  6. 6 IL-33, ST2, and ILC Pathways Immunology 1 works
  7. 7 Protein Degradation and Inhibitors Molecular Biology 1 works
  8. 8 Urticaria and Related Conditions Rheumatology 1 works
  9. 9 RNA Research and Splicing Molecular Biology 1 works
  10. 10 Galectins and Cancer Biology Immunology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.7%not open55.3%

World: 40% of research is openly available.

with international co-authors26.9%domestic only73.1%

World: 18% is written across borders.

How has NKT Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 652% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is NKT Therapeutics (United States) as a percentage of every work published that year, 0.00016% in 2024.

still counting0.00020%0.00040%0.00060%NKT Therapeutics (United States)0.00024% in 2025200020102020

Fractional works of NKT Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Waltham

All research institutions in Waltham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about NKT Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.